CoChat

Telomeric alterations in the default mode network during the progression of Alzheimer's disease: selective vulnerability of the precuneus

Mahady, Laura J., He, Bin, Malek‐Ahmadi, Michael, Mufson, Elliott J. · 2021 · Neuropathology and Applied Neurobiology
Cited by 20

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Aims: Although telomere length (TL) and telomere maintenance proteins (shelterins) are markers of cellular senescence and peripheral blood biomarkers of Alzheimer's disease (AD), little information is available on telomeric alterations during the prodromal stage (MCI) of AD. We investigated TL in the default mode network (DMN), which underlies episodic memory deficits in AD, as well as shelterin protein and mRNA levels in the precuneus (PreC). Methods: Telomere length was evaluated in DMN hubs and visual cortex using quantitative PCR (qPCR). In the PreC, western blotting and NanoString nCounter expression analyses evaluated shelterin protein and mRNA levels, respectively, in cases with an antemortem clinical diagnosis of no cognitive impairment (NCI), MCI and AD. Results: TL was significantly reduced in the PreC in MCI and AD compared to NCI, but stable in frontal, inferior temporal, posterior cingulate and visual cortex. PreC TL correlated significantly with performance on cognitive tests. NCI cases with high vs low Braak scores displayed significantly shorter TL in posterior cingulate and frontal cortex, which correlated significantly with neuritic and diffuse amyloid‐β plaque counts. Shelterin protein levels (TIN2, TRF1, TRF2 and POT1) declined in MCI and AD compared to NCI. The PreC displayed stable expression of shelterins TERF1, TERF2, POT1, RAP1 and TPP1, while TINF2 mRNA significantly increased in AD compared to NCI. Conclusions: These findings indicate a selective vulnerability to telomere attrition within different nodes of the DMN in prodromal AD and in aged NCI individuals with high Braak scores highlighting a putative role in the pathogenesis of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nan.12672

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 82

  1. 10.1212/WNL.0b013e3182231419 · DOI · Paper page
  2. 10.1016/j.biopsych.2013.12.016 · DOI · Paper page
  3. 10.1002/cne.24929 · DOI
  4. 10.1111/bpa.12331 · DOI · Paper page
  5. 10.1016/j.bbr.2008.08.012 · DOI · Paper page
  6. 10.1016/j.neulet.2008.04.021 · DOI · Paper page
  7. 10.1155/2015/583931 · DOI · Paper page
  8. 10.3389/fnins.2016.00582 · DOI
  9. 10.1016/j.neurobiolaging.2017.01.022 · DOI
  10. 10.1159/000492945 · DOI
  11. 10.3233/JAD-122353 · DOI · Paper page
  12. Martinez‐Gonzalez K, 2019, Telomere length and oxidative stress in the progression of Alzheimer’s disease, bioRxiv
  13. 10.1016/j.neuint.2013.02.013 · DOI · Paper page
  14. 10.1101/cshperspect.a012666 · DOI
  15. 10.1002/ajmg.b.32575 · DOI
  16. 10.1016/j.trci.2019.11.003 · DOI · Paper page
  17. Jenkins E, 2015, Telomere longitudinal shortening as a biomarker for dementia status of adults with down syndrome, AM J Med Gen, 171, 169, 10.1002/ajmg.b.32389 · DOI
  18. 10.1093/brain/awl004 · DOI · Paper page
  19. 10.1056/NEJMra0903373 · DOI · Paper page
  20. 10.1128/MCB.00541-16 · DOI
  21. 10.1080/19491034.2015.1048407 · DOI · Paper page
  22. 10.1101/gad.1346005 · DOI · Paper page
  23. 10.4161/nucl.2.2.15135 · DOI · Paper page
  24. 10.1007/s40520-013-0021-1 · DOI
  25. 10.1038/345458a0 · DOI · Paper page
  26. 10.1016/j.exger.2014.06.018 · DOI
  27. 10.1016/j.jalz.2006.03.001 · DOI · Paper page
  28. 10.1016/j.mad.2007.12.004 · DOI · Paper page
  29. 10.3233/JAD-142808 · DOI · Paper page
  30. 10.1002/ana.20894 · DOI · Paper page
  31. 10.1080/01616412.2019.1580456 · DOI
  32. 10.1016/j.mad.2014.10.002 · DOI
  33. 10.3233/JAD-190010 · DOI
  34. 10.1038/labinvest.3780184 · DOI · Paper page
  35. 10.1016/j.jalz.2009.05.666 · DOI · Paper page
  36. 10.1016/j.exger.2011.12.005 · DOI
  37. 10.1016/j.exger.2011.12.005 · DOI
  38. 10.2174/1874609808666150122153151 · DOI · Paper page
  39. 10.1093/nar/gkn1027 · DOI · Paper page
  40. 10.1093/nar/30.10.e47 · DOI · Paper page
  41. 10.1006/exnr.1999.7086 · DOI · Paper page
  42. 10.3233/JAD-141518 · DOI · Paper page
  43. Mai J, 2015, Atlas of the Human Brain
  44. 10.1097/NEN.0b013e318272caab · DOI · Paper page
  45. 10.1016/j.ajpath.2011.10.027 · DOI · Paper page
  46. 10.1212/WNL.59.2.198 · DOI · Paper page
  47. 10.2174/156720512801322591 · DOI · Paper page
  48. 10.1017/S1041610297004985 · DOI
  49. 10.1007/s00401-016-1537-1 · DOI · Paper page
  50. 10.1002/ana.20233 · DOI · Paper page
  51. 10.1214/aos/1013699998 · DOI · Paper page
  52. 10.1038/nsmb.3092 · DOI · Paper page
  53. 10.1097/NEN.0b013e31825018f7 · DOI · Paper page
  54. 10.1016/j.neurobiolaging.2015.10.012 · DOI · Paper page
  55. 10.1016/j.bbr.2016.05.030 · DOI · Paper page
  56. 10.1523/JNEUROSCI.0379-07.2007 · DOI · Paper page
  57. 10.1111/j.1474-9726.2012.00826.x · DOI · Paper page
  58. 10.1111/j.1365-2990.2007.00908.x · DOI
  59. 10.1016/j.freeradbiomed.2007.10.001 · DOI · Paper page
  60. 10.1016/j.neuroscience.2006.11.052 · DOI
  61. Wang X, 2010, Selective neuronal vulnerability to oxidative stress in the brain, Front Aging Neurosci, 2, 12
  62. 10.1016/S0197-4580(02)00043-X · DOI · Paper page
  63. 10.1074/jbc.M409047200 · DOI · Paper page
  64. 10.1038/nature07433 · DOI · Paper page
  65. 10.1038/nature08196 · DOI · Paper page
  66. 10.1016/S0092-8674(00)80932-0 · DOI · Paper page
  67. 10.1038/ncomms6467 · DOI · Paper page
  68. 10.1016/j.diff.2018.06.001 · DOI
  69. 10.1093/brain/awr066 · DOI · Paper page
  70. 10.1038/s41467-017-01313-w · DOI · Paper page
  71. Garcia‐Esparcia P, 2017, Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model, Am J Neurodegener Dis, 6, 15
  72. 10.1101/gad.245662.114 · DOI · Paper page
  73. 10.1371/journal.pone.0053349 · DOI · Paper page
  74. 10.1073/pnas.1516604113 · DOI · Paper page
  75. 10.3389/fnmol.2019.00024 · DOI
  76. 10.1016/j.neuroimage.2009.05.080 · DOI
  77. Trimble M, Handbook of Episodic Memory, 363
  78. 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
  79. 10.1016/j.neurobiolaging.2016.03.003 · DOI
  80. 10.1001/archneur.1995.00540360028012 · DOI · Paper page
  81. 10.1007/s00401-015-1407-2 · DOI · Paper page
  82. 10.1089/rej.2010.1085 · DOI · Paper page

Cited by

See all 20

Metadata

Authors
Mahady, L. J., He, B., Malek‐Ahmadi, M., & Mufson, E. J.
Affiliations
  • Department of Neurobiology Barrow Neurological Institute Phoenix AZ USA
  • Banner Alzheimer’s Institute Phoenix AZ USA
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2020-12-05
Volume
47
Issue
3
Pages
428-440
ISSN
  • 0305-1846
  • 1365-2990
Cited by
20
References
33
Language
en
Funders
  • BrightFocus Foundation
  • Barrow Neurological Foundation
  • National Institute on Aging (P30AG010161, P30AG019610, PO1AG014449, RO1AG042146, RO1AG043375)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomeric alterations in the default mode network during the progression of Alzheimer's disease: selective vulnerability of the precuneus. https://app.cochat.ai/papers/10.1111/nan.12672
The paper
Mahady, L. J., He, B., Malek‐Ahmadi, M., & Mufson, E. J. (2021). Telomeric alterations in the default mode network during the progression of Alzheimer's disease: selective vulnerability of the precuneus. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12672

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.